About: Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1993

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1993 (uk) article scientifique publié en 1993 (fr) im November 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 1993 (ast) scientific article published on 01 November 1993 (en) գիտական հոդված հրատարակված 1993 թվականի նոյեմբերի 1-ին (hy)
publication date	wds:Q72605880-CE346642-56C5-40E4-9EA9-D4F850A15A33
publication date	1993-11-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q72605880-52FDAFAD-091A-4AB1-8CC5-69568F67353B wds:Q72605880-5FE5DF84-D291-4EC6-9770-4F5A817E02AB wds:Q72605880-8C6D9D6C-7E47-4964-8FCC-37CFFB41A0F3 wds:Q72605880-CCDB73BB-8F47-4818-9863-098278C72043 wds:Q72605880-DDC4E125-3154-4AC5-807E-1DE621F42C99
author name string	Cannella B Taubenberger JK McFarland HF Katz D McFarlin DE
rdfs:label	Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis (en) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis (nl)
skos:prefLabel	Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis (en) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis (nl)
name	Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis (en) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis (nl)
author	wds:Q72605880-C36CAF8D-560A-4187-867E-DD7DE01B738B
author	Cedric S Raine
title	wds:Q72605880-1289CF67-CE4F-4455-9146-D84D1CBB33CA
title	Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis (en)
page(s)	wds:Q72605880-9AED81D7-553E-4687-A6B6-48B8E320BA93
page(s)	661-669
instance of	wds:Q72605880-8DC7232F-7095-47EA-9F2A-992B7FAC8311
instance of	scholarly article
main subject	wds:Q72605880-E3894665-45D2-4A71-8576-BB76C2D00FE5
main subject	multiple sclerosis
PubMed ID	wds:Q72605880-0902006E-65FB-4FE0-A236-8CD1321CA267
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8239560
PubMed ID	8239560
published in	wds:Q72605880-9B69B256-277D-431B-8865-195A77EBC178
published in	Annals of Neurology
issue	wds:Q72605880-E3013C2B-948C-4E34-8978-03176A306C14
volume	wds:Q72605880-7B433151-EDCF-4E42-929A-4160C0AD69C5
issue	5
volume	34
DOI	wds:Q72605880-CC4FB040-ED27-4B5D-B141-4CA4B7968A76
DOI	http://dx.doi.org/10.1002/ANA.410340507
DOI	10.1002/ANA.410340507
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72605880
is cites work of	NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. Imaging of multiple sclerosis: role in neurotherapeutics The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis Diffusion tensor imaging of post mortem multiple sclerosis brain. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis. Physicians, subsequence and consequence Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. Energy failure in multiple sclerosis and its investigation using MR techniques Early intervention with immunomodulatory agents in the treatment of multiple sclerosis A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: Correlations with changes of T2 and magnetization transfer lesion loads Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans. Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation From enhancing lesions to brain atrophy in relapsing MS. Translocator protein PET imaging for glial activation in multiple sclerosis Cytokine gene expression in cells derived from CSF of multiple sclerosis patients Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis Natalizumab therapy for multiple sclerosis MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain. Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis Multiple sclerosis: the disease and its manifestations Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group. Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study Overview of diffusion-weighted magnetic resonance studies in multiple sclerosis. Magnetisation transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis MRI monitoring of MS in clinical trials Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. Inflammation in multiple sclerosis: the good, the bad, and the complex Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process The effect of cladribine on T(1) 'black hole' changes in progressive MS. Pathogenetic role of autoantibodies in neurological diseases Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis. Progressive decline in fractional anisotropy on serial DTI examinations of the corpus callosum: a putative marker of disease activity and progression in SPMS Compartmentalization of the immune response in the central nervous system and natural history of multiple sclerosis. Implications for therapy Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software